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Objectives This study evaluated the role of pre-procedural clinical variables to predict procedural and clinical outcomes of
catheter ablation in patients with long-lasting persistent atrial fibrillation (AF).
Background Catheter ablation of persistent AF remains a challenging task.
Methods Catheter ablation was performed in 90 patients (76 men, age 57  11 years) with long-lasting persistent AF.
The history of AF, echocardiographic parameters, presence of structural heart disease, and surface electrocardio-
gram (ECG) AF cycle length (CL) were assessed before ablation and analyzed with respect to procedural termina-
tion and clinical outcome. Mean follow-up was 28  4 months.
Results Persistent AF was terminated in 76 of 90 patients (84%) by ablation. The duration of continuous AF was shorter
(p  0.0001), the surface ECG AFCL was longer (p  0.0001), and the left atrium was smaller (p  0.01) in pa-
tients in whom AF was terminated by catheter ablation. The surface ECG AFCL was the only independent predic-
tor of AF termination (p  0.01). Maintenance of sinus rhythm was associated with a shorter duration of contin-
uous AF (p  0.0001), a longer surface ECG AFCL (p  0.001), and a smaller left atrium (p  0.05) compared
with those with recurrent arrhythmia. In multivariate analysis, the surface ECG AFCL and the AF duration pre-
dicted clinical success of persistent AF ablation (p  0.01 and p  0.05, respectively).
Conclusions The surface ECG AFCL is a clinically useful pre-ablation tool for predicting patients in whom sinus rhythm can be re-
stored by catheter ablation. The duration of continuous AF and the surface ECG AFCL are predictive of maintenance
of sinus rhythm. (J Am Coll Cardiol 2009;54:788–95) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.01.081c
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Ptrial fibrillation (AF) accounts for almost one-third of all
dmissions to a hospital for a cardiac rhythm disturbance.
atheter ablation targeting isolation of the pulmonary veins
PVs) has evolved over the past decade and has become the
reatment of choice for drug-resistant paroxysmal AF. The use
f ablation for treatment of persistent AF has been expanding,
ith more centers now offering the procedure. Catheter abla-
ion can terminate persistent AF and can result in maintenance
f sinus rhythm, at least in the medium term (1–5). The AF
rom the *Hôpital Cardiologique du Haut-Lévêque and the Université Victor
egalen Bordeaux II, Bordeaux, France; and the †Department of Cardiology, Lund
niversity Hospital, Lund, Sweden. Dr. Knecht is supported by the Belgian
oundation for Cardiac Surgery. Dr. Platonov is supported by governmental funding
f clinical research within the Swedish National Healthcare System and The Crafoord
oundation.9
Manuscript received October 15, 2008; revised manuscript received December 2,
008, accepted January 8, 2009.ycle length (CL) measured from the left atrial appendage
LAA) has been used as a predictor of procedural termination
f persistent AF (5); however, this can only be performed at the
See page 796
ime of the procedure. The purpose of this study was to
nvestigate which clinical variables, including a noninvasive
easurement of AFCL from the surface electrocardiogram
ECG), are predictive of a successful procedural and medium-
erm clinical outcome using a sequential catheter ablation
pproach in patients with persistent AF.
ethods
atient population. Of a total of 92 consecutive patients,
0 patients who underwent first-time radiofrequency cath-
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August 25, 2009:788–95 Clinical Predictors for Persistent AF Ablationter ablation for long-lasting persistent AF were included in
he present study, with 2 patients excluded because of
ow-amplitude fibrillatory waves (minimal voltage 0.01
V) that precluded accurate measurement of AFCL from
he surface ECG. Long-lasting persistent AF was defined as
ontinuous AF lasting longer than 1 month, resistant to
ither electrical or pharmacological cardioversion. All pa-
ients gave written informed consent.
lectrophysiological study. All patients had effective an-
icoagulation therapy (target international normalized ratio
f 2 to 3) for more than 1 month, and atrial thrombus was
xcluded by transesophageal echocardiography before the
rocedure. All antiarrhythmic drugs, with the exception of
miodarone, were discontinued 5 half-lives before the pro-
edure. The electrophysiological study was performed in the
asting state under mild sedation using midazolam and
orphine. The following catheters were introduced via the
ight femoral vein: 1) a steerable decapolar catheter (Xtrem,
orin Group, Le Plessis-Robinson, France) was positioned
ithin the coronary sinus; 2) a circumferential mapping
atheter (Lasso, Biosense Webster, Diamond Bar, Califor-
ia) was introduced after transseptal access; and 3) a 4-mm
xternally irrigated-tip ablation catheter (Thermocool, Bio-
ense Webster) was used for mapping and ablation. After
ransseptal access, a single bolus of 50 IU/kg body weight of
eparin was administrated and repeated only for procedures
asting more than 4 h. Surface ECG and endocardial electro-
rams were continuously monitored and recorded for off-line
nalysis (Bard Electrophysiology, Lowell, Massachusetts).
Figure 1 Measurements of AFCL
Simultaneous measurements of the atrial fibrillatory (AF) cycle length (CL) from su
right atrial appendages (LAA and RAA). The AFCL from surface ECG, the LAA, and teasurement of the AFCL
rom surface ECG and intra-
ardiac electrograms. The sur-
ace ECG AFCL was compared
ith the endocardial AFCL ob-
ained simultaneously from the
ntracardiac recordings at both
he LAA and the right atrial
ppendage (RAA) before abla-
ion. In all patients, the surface
CG AFCL was manually mea-
ured from 10 unambiguous
brillatory waves on lead V1
minimal voltage 0.01 mV)
hat were not fused with QRST
egments (Fig. 1) at a paper
peed of 50 mm/s and a gain
etting of 20, 40, or 80 mm/mV.
he mean LAA CL and RAA CL were calculated using
ustom software (Bard Electrophysiology) with manual
erification (5).
In the first 30 patients, intraobserver and interobserver
rror of the surface ECG AFCL from 10 CL was assessed.
he surface ECG AFCL from 10 CL was measured on 2
ifferent days and using 2 independent experts, respectively.
he mean surface ECG AFCL from 10 CL was compared
ith that from 30 CL (manually measured) and with the
ean AFCL using automated time frequency analysis
TFA) of 60 s of simultaneous surface ECG recording as
lectrocardiogram (ECG) and the left and
A in this case were 139, 144, and 145 ms, respectively.
Abbreviations
and Acronyms
AF  atrial fibrillation
CI  confidence interval
CL  cycle length(s)
ECG  electrocardiogram
LA  left atrium
LAA  left atrial
appendage
PV  pulmonary vein
RAA  right atrial
appendage
ROC  receiver-operator
characteristic
TFA  time frequency
analysisrface e
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Clinical Predictors for Persistent AF Ablation August 25, 2009:788–95reviously described (6,7). Digital measurement of fibrilla-
ory rates using TFA was disqualified because of poor signal
uality in 4 patients.
blation of long-lasting persistent AF. In all patients,
equential stepwise ablation was performed as previously
escribed (5), involving PV isolation, electrogram-based
blation, and linear ablation. Ablation around the PVs was
erformed with the aid of a Lasso catheter. The end point
f this step was the elimination or dissociation of the PV
otentials as determined by a Lasso catheter in all veins.
solation of the PVs was confirmed after restoration of sinus
hythm. After this, electrogram-based ablation was per-
ormed at sites in the left atrium (LA) showing any of the
ollowing electrogram features: continuous electrical activ-
ty, complex rapid and fractionated electrograms, and a
radient of activation (a temporal gradient of at least 70 ms
etween the distal and proximal bipoles on the roving distal
blation electrode, potentially representing a local circuit).
inear ablation in the LA was performed if AF persisted
fter electrogram-based ablation. A roof line was performed
oining the right and left superior PVs, and if AF continued,
mitral isthmus line from the mitral annulus to the left
nferior PV was performed as previously described (5). After
estoration of sinus rhythm, assessment of conduction block
cross the lines was performed in all patients with supple-
entary ablation, if necessary, to achieve block (8). A
avotricuspid isthmus line was performed in all patients
ith an end point of bidirectional block.
rocedural end point of long-lasting persistent AF abla-
ion. The procedural end point was termination of long-
asting persistent AF by catheter ablation, either by conver-
ion directly to sinus rhythm or via one or more atrial
achycardias, which were subsequently mapped and ablated
5). When AF was not terminated by ablation, it was
erminated by electrical cardioversion (procedural failure).
fter cardioversion, if necessary, supplemental radiofre-
uency energy was delivered to establish PV isolation and
onduction block of any linear lesion.
linical outcome of long-lasting persistent AF ablation.
uccess was defined as maintenance of sinus rhythm without
ntiarrhythmic drug treatment more than 12 months after the
nal procedure. Failure was defined as documented recurrence
f AF or atrial tachycardia lasting for more than 3 min.
ollow-up. Patients were hospitalized for between 3 and 5
ays post-procedure and seen at 1, 3, 6, and 12 months for
linical interview, echocardiography, and 24-h ambulatory
onitoring in addition to routine follow-up by the referring
ardiologist. One year from the last procedure, patients were
een every 6 months by their referring cardiologist. All patients
nderwent 24-h Holter monitoring within the last 3 months of
ollow-up. Antiarrhythmic medication was continued for 1 to
months after the index procedure, and anticoagulation
reatment was continued for at least 6 months. A repeat
blation procedure was undertaken in the event of a recurrence
f AF or atrial tachycardia lasting more than 3 min.
tatistical analysis. Linear regression analysis was used toest the association between the surface ECG AFCL from
d
v0 CL and 30 CL, TFA of a 60-s sample window, LAA
FCL, RAA AFCL, and procedure time. A Bland-Altman
lot was generated to examine the precision between the
AA CL and the surface ECG AFCL from 10 CL, 30 CL,
nd TFA. To evaluate intraobserver and interobserver
ariability, the Pearson correlation coefficient (r) was calcu-
ated for the surface ECG AFCL from 10 CL.
Continuous variables are expressed as mean  SD or
edian with interquartile range where indicated. Statistical
ignificance was assessed using the unpaired Student t test
r Mann-Whitney U test if necessary. Categorical variables,
xpressed as numbers or percentages, were analyzed using
he chi-square test or Fisher exact test. To analyze indepen-
ent predictive factors of termination of AF during ablation
nd independent factors of clinical success, univariate fac-
ors presenting p  0.1 were analyzed using logistic regres-
ion (multivariate analysis). The receiver-operator charac-
eristic (ROC) curve was determined to evaluate the
erformance of the best independent predictor of AF
ermination by catheter ablation. The optimal cutoff point
as chosen as the combination with the highest sensitivity
nd specificity. All tests were 2-tailed, and p  0.05 was
onsidered significant. Cumulative event rates (recurrence
f arrhythmia) were calculated according to the Kaplan-
eier method.
esults
atient population. The baseline characteristics of the
verall study population are shown in Table 1. The mean
ge was 57  11 years (median 56 years, interquartile range
0 to 64 years); 84% (76) were male. The mean duration of
ontinuous AF was 28  31 months (median 19 months,
nterquartile range 9 to 36 months), and 28% (25 of 90) of
atients took amiodarone within 3 months of the procedure.
atients were followed up for a mean of 28  4 months
median 27 months, interquartile range 24 to 30 months)
fter the first ablation procedure. Patients were later cate-
orized according to whether or not persistent AF was
erminated by catheter ablation and whether or not atrial
rrhythmia recurred after the final ablation procedure.
atient Characteristics ofhe Overall Population Study (n  90)Table 1 Pa ient Characteristics ofthe Overall Population Study (n  90)
Age (yrs) 56.5 10.6
Sex (male/female) 76/14
Duration of AF (months) 27.8 31.1
Hypertension 24
Structural heart disease 25
LAD (mm) 48.4 7.9
LVEF (%) 59.4 13.5
Number of AAD 2.7 1.0
Administration of amiodarone 25
Number of DCC 1.7 2.1
Surface ECG AFCL (ms) 150.0 18.5
AD  antiarrhythmic drugs; AF  atrial fibrillation; AFCL  atrial fibrillatory cycle length; DCC 
irect cardiac compressions; ECG  electrocardiogram; LAD  left atrial dimension; LVEF  left
entricular ejection fraction.
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August 25, 2009:788–95 Clinical Predictors for Persistent AF Ablationalidation of surface ECG AFCL from 10 fibrillatory
aves. Intraobserver and interobserver correlations were
igh in the measurement of the AFCL from the surface
CG using 10 CL (R  0.97 and R  0.98, respectively).
n first 30 patients, surface ECG AFCL was calculated
sing manual measurement of 10 and 30 CL and the use of
FA analysis of a 60-s simultaneous recording window.
here was a strong correlation between the AFCL from the
urface ECG measured with 10 and 30 CL (R 0.984, p
.0001) (Fig. 2A) and between the surface ECG AFCL
alculated manually using 10 CL and digital measurement
sing TFA (R  0.941, p  0.0001) (Fig. 2B).
orrelation of surface AFCL and intracardiac AFCL.
he mean surface ECG AFCL from 10 CL and LAA and
AA AFCL of the total population were 150 19 ms, 153
20 ms, and 157  20 ms, respectively. The mean surface
CG AFCL was longer in patients taking amiodarone (163
18 ms vs. 146  16 ms, p  0.0001). The mean
ifferences between the surface ECG AFCL from 10 CL
nd the endocardial AFCL in the LAA and RAA were 7
ms and 8  8 ms, respectively. The surface ECG AFCL
rom 10 CL was strongly correlated with both the LAA CL
R  0.893, p  0.0001) and the RAA CL (R  0.876,
 0.0001) (Figs. 2C and 2D).
Figure 2 AFCL Correlation
Relationship between (A) mean surface ECG AFCL measurement from 10 and 30
frequency analysis (TFA), (C) surface ECG AFCL from 10 CL and the LAA CL, and (Additionally, Bland-Altman plots show good agree-
ent between the RAA CL versus the AFCL from TFA
Fig. 3A), the RAA CL versus the manual measurement
urface ECG AFCL from 30 CL (Fig. 3B), and the RAA
L versus the manual measurement surface ECG AFCL
rom 10 CL (Fig. 3C).
linical variables and procedural termination of persis-
ent AF. Long-lasting persistent AF was terminated by
blation in 76 of 90 patients (84%), with a mean
rocedure time of 245  70 min. Pre-procedural clinical
ariables were compared in patients in whom AF was
erminated by ablation versus in those who were not
Table 2). Compared with patients in whom AF was not
erminated, patients with AF termination had a signifi-
antly shorter duration of continuous AF (22  24
onths vs. 60  44 months, p  0.0001), a longer
urface ECG AFCL (154  17 ms vs. 132  10 ms, p 
.0001), and a smaller LA dimension (47  7 mm vs.
4  11 mm, p  0.01). Using multivariate analysis
Table 3), the surface ECG AFCL was the only inde-
endent predictor of AF termination by catheter ablation
p  0.005). There was a trend toward duration of
ontinuous AF predicting AF termination (p  0.08),
ut LA dimension was not an independent predictor.
) surface ECG AFCL from 10 CL and AFCL using time
face ECG AFCL from 10 CL and the RAA CL. Abbreviations as in Figure 1.CL, (B
D) sur
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Clinical Predictors for Persistent AF Ablation August 25, 2009:788–95The ROC curve for the surface ECG AFCL as a
redictor of termination of long-lasting persistent AF
howed an area under the curve of 0.880 (95% confidence
nterval [CI]: 0.795 to 0.939, p  0.0001) (Fig. 4). A cutoff
oint of 142 ms of the AFCL (Fig. 4, arrow) had a
pecificity of 92.9% and a sensitivity of 69.7% in predicting
rocedural termination of persistent AF. The positive and
Figure 3 Invasive and Noninvasive Measurement of AFCL
Bland-Altman plots showing the systematic difference between the RAA CL and
(A) AFCL using time frequency analysis (TFA), (B) surface ECG AFCL from 30
CL, and (C) surface ECG AFCL from 10 CL. Abbreviations as in Figure 1.egative predictive value of the AFCL142 ms were 98.1% And 36.1%, respectively, for procedural termination of per-
istent AF. There was an inverse relationship between
rocedural time and the surface ECG AFCL (R  0.55,
 0.0001).
For the association between the duration of continuous
F and procedural termination, the area under the ROC
urve was calculated to be 0.844 (95% CI: 0.752 to 0.912,
 0.0001) (Fig. 4). The optimal cutoff point for the
uration of continuous AF was 21 months for AF termi-
ation (specificity 92.9%, sensitivity 61.8%). The combined
utoff using a surface ECG AFCL 142 ms and a duration
f continuous AF 21 months had 100.0% specificity in
redicting procedural termination of persistent AF (sensi-
ivity 39.5%, positive predictive value 100.0%, negative
redictive value 23.3%).
linical variables and clinical outcome. After the final
rocedure (mean number of procedures 1.8  0.8 [1 to 4]),
4% (76 of 90) of patients were in sinus rhythm without
ntiarrhythmic drug treatment during follow-up of 18  6
onths (median 18 months, interquartile range 12 to 24
onths). The clinical characteristics are shown in Table 4.
here was no difference in total number of procedures
etween patients with and without recurrence (1.8 0.8 vs.
.9  0.9, p  NS). The duration of continuous AF (57 
4 months vs. 23 21 months, p 0.0001) and the surface
CG AFCL were longer (154  18 ms vs. 136  11 ms,
 0.001) in patients with recurrence of arrhythmia than in
hose who maintained sinus rhythm without antiarrhythmic
rugs. The dimension of the LA was smaller (48  8 mm
s. 53  8 mm, p  0.05) in patients with a successful
edium-term outcome. There was a trend toward lower left
omparison Characteristics Betweenatients With and Without AF Termi ationTable 2 omparison Characteristics BetweenPatients With and Without AF Termination
AF Termination
(n  76)
Non-AF Termination
(n  14) p Value
Duration of AF (months) 22 24 60 44 0.0001
Surface ECG AFCL (ms) 154.3 16.9 131.7 9.6 0.0001
LAD (mm) 47.4 6.9 53.8 10.5 0.01
Age (yrs) 56.2 10.7 58.1 10.0 0.52
Sex (male/female) 64/12 12/2 0.88
LVEF (%) 59.1 14.2 61.1 9.5 0.61
Hypertension 21 3 0.63
Structural heart disease 23 2 0.21
Number of AAD 3.0 0.8 2.7 1.0 0.26
Administration of
amiodarone
21 4 0.94
Number of DCC 1.8 1.4 1.8 2.2 0.93
bbreviations as in Table 1.
ultivariate Analysisf Predictors of AF TerminationTable 3 Multivariate Analysisof Predictors of AF Termination
p Value 95% Confidence Interval
Surface ECG AFCL 0.005 1.04–1.28
Duration of AF 0.08 0.84–1.01
LAD 0.22 0.86–1.04bbreviations as in Table 1.
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August 25, 2009:788–95 Clinical Predictors for Persistent AF Ablationentricular ejection fraction in patients with arrhythmia
ecurrence after the final ablation (53  10% vs. 60  14%,
 0.08). In multivariate analysis, the surface ECG AFCL
nd the duration of continuous AF independently predicted
linical outcome of persistent AF ablation (p  0.01 and
 0.05, respectively) (Table 5). Patients with a surface
CG AFCL 142 ms had a significantly higher rate of
ecurrent arrhythmia (p  0.001, hazard ratio: 6.0, 95% CI:
.0 to 18.5) (Fig. 5A). Additionally, arrhythmia recurrence
fter the final ablation was frequently observed in patients
ith duration of continuous AF 21 months compared
ith those with persistent AF lasting 21 months (p 
.002, hazard ratio: 0.13, 95% CI: 0.06 to 0.51) (Fig. 5B).
Figure 4 Termination of Persistent
AF and AFCL/Duration of AF
The receiver-operator characteristic (ROC) curve analysis of the AFCL from sur-
face ECG (solid red line) and duration of persistent AF (dotted blue line)
according to termination of persistent AF by catheter ablation. Arrows indicate
optimal cutoff point for sensitivity and specificity. CI  confidence interval;
other abbreviations as in Figure 1.
omparison Characteristics Between Patientsith nd Wit out Recurrence of ArrhythmiaTable 4 Comparison Charact ristics Be ween PatientsWith and Without Recurrence of Arrhythmia
No Recurrence
(n  76)
Recurrence
(n  14) p Value
Duration of AF (months) 23 21 57 54 0.0001
Surface ECG AFCL (ms) 153.5 17.7 136.3 11.1 0.001
LAD (mm) 47.5 7.6 53.0 8.1 0.02
Age (yrs) 55.9 11.0 59.4 8.2 0.27
Sex (male/female) 64/12 12/2 0.88
LVEF (%) 60.6 13.9 53.6 9.7 0.08
Hypertension 21 3 0.63
Structural heart disease 23 2 0.21
Number of AAD 2.8 1.0 2.5 0.9 0.35
Administration of
amiodarone
23 2 0.22
Number of DCC 1.8 2.2 1.5 1.1 0.77bbreviations as in Table 1.rocedural termination and clinical outcome. Recur-
ence of arrhythmia after the index procedure was observed
n 69% (62 of 90) of patients. Recurrence of AF after the
Figure 5 Freedom From Arrhythmia
Recurrence After Persistent AF Ablation
(A) Kaplan-Meier curve analysis of the incidence of recurrent arrhythmia after
the last procedure in patients with or without the AFCL from surface ECG 142
ms. (B) Kaplan-Meier curve analysis of the incidence of recurrent arrhythmia
after the last procedure in patients with or without the duration of persistent
AF 21 months. CI  confidence interval; other abbreviations as in Figure 1.
ultivariate Analysisf Predictors of Clinical OutcomeTable 5 Multivariate Analysisof Predictors of Clinical Outcome
p Value
Hazard
Ratio
95% Confidence
Interval
Surface ECG AFCL 0.009 0.93 0.88–0.98
Duration of AF 0.047 0.95 0.90–0.99
LAD 0.22 1.01 0.95–1.08
LVEF 0.51 1.01 0.99–1.02
bbreviations as in Table 1.
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Clinical Predictors for Persistent AF Ablation August 25, 2009:788–95ndex procedure was observed more frequently in patients
ith clinical failure compared with those with clinical
uccess (93% [13 of 14] vs. 4% [3 of 76], p 0.0001). In the
emaining patients with recurrent arrhythmia, atrial tachy-
ardia was observed and was terminated during the repeat
blation procedure. Additionally, procedural AF termina-
ion during the index procedure was associated with clinical
uccess (92% [70 of 76] vs. 43% [6 of 14], p  0.0001).
iscussion
ain findings. The present study evaluated the relation-
hip between clinical variables and the procedural and
linical outcomes of catheter ablation for long-lasting per-
istent AF. Multivariate analysis showed that the surface
CG AFCL independently predicts procedural termination
sing the sequential stepwise approach. Furthermore, pa-
ients with a longer surface ECG AFCL and a shorter
uration of continuous AF have a better outcome of
atheter ablation.
alidation of AFCL from surface ECG. The surface
CG AFCL manually assessed from 10 CL correlated well
ith the AFCL recorded by intracardiac catheters in the
AA and RAA, and using TFA, confirming previous
tudies that have shown that AFCL can reliably be assessed
rom lead V1 on the surface ECG (Fig. 2) (6,7). The
bsolute difference between the surface AFCL and the
ntracardiac CL (both LAA CL and RAA CL) was similar
o that of a previous study using digital signal processing (6).
linical variables and ablation results. The procedural
nd point in this study was termination of persistent AF,
nd this was achieved in the majority of patients. This study
hows that a longer surface ECG AFCL, a shorter duration
f continuous AF, and a smaller LA dimension are predic-
ive of procedural AF termination. A shorter surface ECG
FCL was associated with longer procedural times, sug-
esting that the results are not caused by operator bias, but
y an increased complexity of AF. The complexity of AF
nd its association with the AFCL has been suggested by
revious studies (9). In a canine model of AF, a shorter
FCL was observed in chronic AF compared with acute AF
nd there was a significant reduction in the endocardial atrial
ffective refractory period (10). In that study, the mean AFCL
as correlated with the local epicardial refractory period and
he marked changes in atrial architecture, such as fiber disarray
nd early hypertrophy, which could contribute to the mainte-
ance of AF. Cryoablation directed to sites of the shortest local
FCL resulted in termination of sustained AF after prolon-
ation of AFCL in that study (11). Although AFCL measured
rom the LAA is correlated with procedural outcome (5),
FCL calculated from the surface ECG is noninvasive and
an be performed at the initial consultation.
re-procedural clinical variables and clinical outcome.
n patients with persistent AF, restoration and maintenance of
inus rhythm can be attempted by drug treatment and/or
lectrical cardioversion. Previous studies have shown that the
nergy requirements, rate of AF recurrence, and long-term afficacy of antiarrhythmic treatment can be predicted from the
urface ECG AFCL (12–14). The present study shows that an
FCL 142 ms predicts the outcome of catheter ablation.
he agreement between these studies suggests that surface
CG AFCL is a powerful predictor of clinical outcome.
The durations of continuous AF and LA dimensions are
redictive of maintenance of sinus rhythm after DC cardio-
ersion (15–17). Although it has previously been reported that
trial electrical remodeling can develop quickly (18), anatom-
cal remodeling resulting in enlargement of the LA continues
or a long period (19). The importance of LA size in the
evelopment of AF and in determining the long-term result of
ardioversion has long been known (20). In the present study,
he duration of continuous AF was independently predictive of
rrhythmia recurrence after catheter ablation, whereas LA
imension and the presence of hypertension were not, in
ontrast to a previous study (21). This may be attributable to
atient selection and the definition of success. In this study all
atients had persistent AF lasting for more than 1 month,
ompared with 39% in the earlier study. Additionally, atrial
achycardia as well as AF was included as a recurrent
rrhythmia in the present study. Finally, the success rate of
atheter ablation to treat persistent AF ranges from 60% to
0%, depending on the patient’s series and ablation strategies
3–5,22,23). The different success rate according to strategy to
reat persistent AF patients may result in different predictors of
rrhythmia recurrence after catheter ablation.
ffects of amiodarone on the surface ECG AFCL and
blation results. In the present study, although the surface
CG AFCL was longer in patients taking amiodarone
ompared with those not, the ablation results (procedural
ermination and maintenance of sinus rhythm after abla-
ion) did not differ between the 2 groups. Atrial fibrillation
as been shown to shorten the action potential duration and
he atrial effective refractory period (electrical remodeling)
hile administration of antiarrhythmic agents such as ami-
darone lengthen the atrial effective refractory period
24). A previous study has shown that the degree of
omplexity of endocardial atrial activation during AF was
eflected on the surface ECG (25). A longer surface ECG
FCL in patients taking amiodarone could be led by
rolongation of the atrial refractory period, resulting in
rganization of AF. However, the underlying progression
f the electrical remodeling in patients with amiodarone
ay be masked and underestimated.
linical implications. Currently there is an inability to
ffer AF ablation for all patients with persistent AF, and the
ptimal selection for catheter ablation has yet to be deter-
ined. This study suggests that it may be prudent to refer
atients with persistent AF of2 years’ duration. However,
hen the duration of continuous AF is more than 2 years or
he duration is unclear, the surface ECG AFCL can help
he physician decide whether or not to recommend ablation
herapy in the outpatient clinic.
tudy limitations. This was a retrospective study, and the
ata may only apply to patients in whom a stepwise ablation
pproach is performed. Repeat procedures were performed
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inus rhythm without the need for antiarrhythmic medica-
ion. We measured the surface ECG AFCL using a
omputer-based system that allows modification of gain and
weep speed. It is sometimes difficult to assess the AFCL on
he surface ECG using conventional settings, and therefore
e recommend that multiple settings are used to get
nequivocal f waves on the surface ECG. There were only
patients in whom the AFCL was unable to be calculated
rom the surface ECG, and the findings are only relevant
hen the AFCL can be calculated.
We did not analyze other potential predictors for AF
ecurrence after ablation, especially intraoperative parameters
ncluding procedural termination of long-lasting persistent AF,
ecause we were aware that it would have been difficult to
xamine all possible risk factors, and we focused on clinical
actors that can be assessed before ablation. Another limitation
as the small sample size and the multiple variables entered
nto the multivariate model. Therefore, the findings might be
nfluenced by the confounding effects of measured or
nmeasured clinical variables. Additionally, in the present
tudy the patients were followed up for only a midterm
eriod; further research is required to evaluate our results for
ong-term clinical outcome.
Finally, we did not assess quality of life in this study.
lthough this study shows that sinus rhythm can be
estored and maintained by ablation, further studies are
equired to determine whether this results in an improved
uality of life in this population.
onclusions
his study confirms that long-lasting persistent AF can be
erminated and potentially cured by catheter ablation. The
urface ECG AFCL independently predicts procedural termi-
ation of persistent AF, and both the surface ECG AFCL and
he duration of continuous AF are predictive of clinical
utcome. The measurement of the surface ECG AFCL and
he duration of continuous AF could help with patient selec-
ion for catheter ablation of long-lasting persistent AF.
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